SEC Form 4 · accession 0000899243-17-018069
Calithera Biosciences, Inc. · CALA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Curtis Hecht
Officer — SVP, BUS. & CORP. DEVELOPMENT
Period of report
Jul 6, 2017
Accepted (ET)
Jul 7, 2017 · 4:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001496671
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2 | Jul 6, 2017 | S | 700 | $18.00 | D | 15,940 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Reported transaction occurred pursuant to a Rule10b5-1 Trading Plan adopted on September 14, 2015 and includes 700 shares acquired under the Company's 2014 Employee Stock Purchase Plan.
- F2Includes 1,730 shares acquired under the Company's 2014 Employee Stock Purchase Plan on June 9, 2017.